Dr Andrew Blackwell, Chief Scientific Officer, talks about the launch of the CTIS - Product 2 and the first mover advantage they on a market that exceeds GBP105m.
- Forums
- International Markets
- News: Cambridge Cognition - Launch of CTIS-Profile 2+ on Cantab Connect
News: Cambridge Cognition - Launch of CTIS-Profile 2+ on Cantab Connect
Featured News
Featured News
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online